Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNA-Vaccinated People Against Wild-Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern

The rapid development, approval, and production of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in less than 1 year after the first reports of a new infectious disease was a real game changer, providing 80%–90% efficacy in preventing severe etiopathologies of the...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Mandy Schwarze, Andor Krizsan, Alexandra Brakel, Fabian Pohl, Daniela Volke, Ralf Hoffmann
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Subjects:	angiotensin-converting enzyme-2 (ACE-2) BNT162b2 ELISA mRNA-1273 receptor-binding domain (RBD) SARS-CoV-2
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.915034/full